Connect Biopharma drops after Phase 2 rademikibart endpoint miss
Connect Biopharma plunged after Phase 2 Seabreeze missed the primary endpoint for rademikibart in asthma, despite halving ED/unscheduled visits and improving lung function as a secondary endpoint.